Hormone Therapy 2013 Global Consensus Statement

“This document serves to emphasize international consensus regarding MHT and is aimed at empowering women and healthcare practitioners in the…”.1

Umbrella
What may the Hormone Therapy 2013 Global Consensus Statement Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Global Consensus Statement on Menopausal Hormone Therapy
  • Hormone Replacement Therapy (HRT)
  • Hormone Therapy (HT)
  • Menopausal Hormone Therapy (MHT)

Background

What is the background for the Global Consensus Statement on Menopausal Hormone Therapy?

In the Global Consensus Statement on Menopausal Hormone Therapy published in 2013, the authors elaborate on:

“…The International Menopause Society took the initiative to arrange a round-table discussion, in November 2012, between representatives of the major regional menopause societies to reach consensus on core recommendations regarding MHT”.2

What is MHT?

MHT can be an abbreviation for Menopausal Hormone Therapy.

Organizations

Which organizations endorse the Global Consensus Statement?

Organization which endorse the Global Consensus Statement (in alphabetical order) are the:

Organizations

  1. American Society for Reproductive Medicine
  2. Asia Pacific Menopause Federation
  3. Endocrine Society
  4. European Menopause and Andropause Society
  5. International Menopause Society
  6. International Osteoporosis Foundation
  7. North American Menopause Society

Aim

What is the aim of the Global Consensus Statement?

In Global Consensus Statement on Menopausal Hormone Therapy published in 2013, the authors explain:

“The aim was to produce a short document in bullet-point style, only containing the points of consensus”.3

Acknowledgement

What did the Global Consensus Statement acknowledge?

The authors of the Global Consensus Statement acknowledge:

“It is acknowledged that, in view of the global variance of disease and regulatory restrictions, these core recommendations do not replace the more detailed and fully referenced recommendations prepared by individual national and regional societies. This document serves to emphasize international consensus regarding MHT and is aimed at empowering women and healthcare practitioners in the appropriate use of MHT”.4

Consensus

What are some points of consensus in the Global Consensus Statement?

Some points of consensus are:

  • “MHT is the most effective treatment for vasomotor symptoms associated with menopause at any age, but benefits are more likely to outweigh risks for symptomatic women before the age of 60 years or within 10 years after menopause
  • MHT is effective and appropriate for the prevention of osteoporosis-related fractures in at-risk women before age 60 years or within 10 years after menopause
  • Local low-dose estrogen therapy is preferred for women whose symptoms are limited to vaginal dryness or associated discomfort with intercourse”.5

Vasomotor Symptoms

What are vasomotor symptoms?

DotS the definition of vasomotor symptoms may vary. The North American Menopause Society’s definition is:

“Vasomotor symptoms. Also known as hot flashes and night sweats, common symptoms during perimenopause and early postmenopause”.6

Review

Is the Global Consensus Statement to be reviewed?

The authors of the Global Consensus Statement note:

“These core recommendations will be reviewed in the future as new evidence becomes available”.7

Revised Global Consensus Statement

When was the Revised Global Consensus Statement on Menopausal Hormone Therapy published?

The Revised Global Consensus Statement on Menopausal Hormone Therapy was published online 20 June 2016.

Health Care Provider

What if I choose to use MHT?

If you choose to use MHT, it may be in your best interest to also choose to talk to your health care provider about this.

One of the points of consensus in the Revised Global Consensus Statement on Menopausal Hormone Therapy: Section B: General Principles Governing the Use of MHT published in 2016, is:

  • “The option of MHT is an individual decision in terms of quality of life and health priorities as well as personal risk factors such as age, time since menopause and the risk of VTE, stroke, ischemic heart disease and breast cancer. MHT should not be recommended without a clear indication for its use”.8

Health Topics A-Z

Where may I find Health Topics related to Hormone Therapy 2013 Global Consensus Statement?

In Health Topics A-Z you may find:

Health Topics A-Z

Links

Where may I find Links related to Hormone Therapy 2013 Global Consensus Statement?

Your Country may have Links similar to:

Links

This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.

  1. 15 Top Medical Organizations Agree on Hormone Therapy Use: 10 Years Have Passed Since Women’s Health Initiative Raised Questions
  2. 2016 IMS Recommendations on Women’s Midlife Health and Menopause Hormone Therapy
  3. 9 Myths and Misunderstandings About Menopausal Hormone Therapy (MHT)
  4. A Decade After the Women’s Health Initiative–the Experts Do Agree
  5. Combined Menopausal Hormone Therapy (MHT)
  6. Deciding About Hormone Therapy
  7. Deciding About Hormone Therapy Use
  8. Decidir Sobre La Hormonoterapia
  9. Global Consensus Statement on Menopausal Hormone Therapy
  10. HRT and Breast Cancer: Overall Risks and Benefits Explained – A British Menopause Society Video
  11. HRT and the Risk of Breast Cancer Explained – A British Menopause Society Video
  12. HRT: Benefits and Risks
  13. Hormone Replacement Therapy (HRT) Explained – A British Menopause Society Video
  14. Hormone Therapy: Is It Right for You?
  15. Making Sense of Menopausal Hormone Therapy Means Understanding the Benefits As Well As the Risks
  16. Menopausal Hormone Therapy Trends Before Versus After 2002: Impact of the Women’s Health Initiative Study Results
  17. Menopause
  18. Menopause FAQs: Hot Flashes – Q. Are there treatments for hot flashes?
  19. Menopause Hormone Therapy: Follow-Up Appointments?
  20. Menopause Hormone Therapy: Who Shouldn’t Take It?
  21. Menopause: Diagnosis and Management – Information for the Public: Questions To Ask About Menopause [NICE Guideline]
  22. Menopause: Is Menopausal Hormone Therapy (HRT) Safe? [Multiply Languages] [Video]
  23. Menopause: Medicines To Help You
  24. Menopause: Menopause – Hormone Treatments
  25. Menopause: What Is Menopausal Hormone Therapy (HRT)? [ Multiply Languages] [Video]
  26. NAMS 2017 Position Statement Updates Guidelines for Hormone Therapy Use
  27. National Center for Complementary and Integrative Health: Menopausal Symptoms: In Depth
  28. Position Papers and Consensus Statements: Global Consensus Statement on Menopausal Hormone Therapy [Multiply Languages]
  29. Oestrogen Only Menopausal Hormone Therapy
  30. Revised Global Consensus Statement on Menopausal Hormone Therapy
  31. Risks and Benefits of MHT
  32. The Experts Do Agree About Hormone Therapy
  33. Tipos de Hormonoterapia
  34. Types of Hormone Therapy
  35. Video Series-2020: TSECs—A New Treatment for Hot Flashes and Night Sweats
  36. Video Series-2020: What You Need to Know About Bioidentical Hormone Therapy
  37. Video Series-2021: Treatment Options for Vaginal Dryness and Urinary Issues
  38. Video Series-2021: What Women Need to Know About Hormone Therapies
  39. Webinars: Previous – 2021 Vision: Practical Steps To Optimize Your Benefit-Risk. Discussions for A New Decade
  40. What Is Menopausal Hormone Therapy (MHT) and Is It Safe?

Sources

Where may I find the Sources quoted?

You may find the Sources quoted at:

Sources

  1. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/wp-content/uploads/2020/08/hrt-2013-06-english.pdf Accessed: 01 November 2021
  2. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/wp-content/uploads/2020/08/hrt-2013-06-english.pdf Accessed: 01 November 2021
  3. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/wp-content/uploads/2020/08/hrt-2013-06-english.pdf Accessed: 01 November 2021
  4. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/wp-content/uploads/2020/08/hrt-2013-06-english.pdf Accessed: 01 November 2021
  5. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/wp-content/uploads/2020/08/hrt-2013-06-english.pdf Accessed: 01 November 2021
  6. Menopause Glossary: V – Vasomotor Symptoms. North American Menopause Society https://www.menopause.org/for-women/menopause-glossary Accessed: 01 November 2021
  7. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:204 https://www.imsociety.org/wp-content/uploads/2020/08/hrt-2013-06-english.pdf Accessed: 01 November 2021
  8. De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Section B: General Principles Governing the Use of MHT. Climacteric, 2016;19:4:314 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 01 November 2021

Topic Last Updated: 01 November 2021 – Topic Last Reviewed: 01 November 2021
Print Friendly, PDF & Email
/by